rs4646179

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001371415.1(ACE2):ā€‹c.2070T>Cā€‹(p.Asn690=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00377 in 1,209,518 control chromosomes in the GnomAD database, including 101 homozygotes. There are 1,221 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.018 ( 45 hom., 527 hem., cov: 23)
Exomes š‘“: 0.0023 ( 56 hom. 694 hem. )

Consequence

ACE2
NM_001371415.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0640
Variant links:
Genes affected
ACE2 (HGNC:13557): (angiotensin converting enzyme 2) The protein encoded by this gene belongs to the angiotensin-converting enzyme family of dipeptidyl carboxydipeptidases and has considerable homology to human angiotensin 1 converting enzyme. This secreted protein catalyzes the cleavage of angiotensin I into angiotensin 1-9, and angiotensin II into the vasodilator angiotensin 1-7. ACE2 is known to be expressed in various human organs, and its organ- and cell-specific expression suggests that it may play a role in the regulation of cardiovascular and renal function, as well as fertility. In addition, the encoded protein is a functional receptor for the spike glycoprotein of the human coronavirus HCoV-NL63 and the human severe acute respiratory syndrome coronaviruses, SARS-CoV and SARS-CoV-2, the latter is the causative agent of coronavirus disease-2019 (COVID-19). Multiple splice variants have been found for this gene and the dACE2 (or MIRb-ACE2) splice variant has been found to be interferon inducible. [provided by RefSeq, Nov 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant X-15566297-A-G is Benign according to our data. Variant chrX-15566297-A-G is described in ClinVar as [Benign]. Clinvar id is 778980.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.064 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0592 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ACE2NM_001371415.1 linkuse as main transcriptc.2070T>C p.Asn690= synonymous_variant 16/18 ENST00000252519.8 NP_001358344.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ACE2ENST00000252519.8 linkuse as main transcriptc.2070T>C p.Asn690= synonymous_variant 16/181 NM_001371415.1 ENSP00000252519 P1Q9BYF1-1

Frequencies

GnomAD3 genomes
AF:
0.0181
AC:
2026
AN:
111676
Hom.:
45
Cov.:
23
AF XY:
0.0155
AC XY:
526
AN XY:
33866
show subpopulations
Gnomad AFR
AF:
0.0617
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00741
Gnomad ASJ
AF:
0.00794
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000375
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00844
Gnomad NFE
AF:
0.000376
Gnomad OTH
AF:
0.0113
GnomAD3 exomes
AF:
0.00561
AC:
1026
AN:
182741
Hom.:
23
AF XY:
0.00355
AC XY:
239
AN XY:
67285
show subpopulations
Gnomad AFR exome
AF:
0.0649
Gnomad AMR exome
AF:
0.00319
Gnomad ASJ exome
AF:
0.00576
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000158
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000355
Gnomad OTH exome
AF:
0.00245
GnomAD4 exome
AF:
0.00231
AC:
2535
AN:
1097790
Hom.:
56
Cov.:
29
AF XY:
0.00191
AC XY:
694
AN XY:
363200
show subpopulations
Gnomad4 AFR exome
AF:
0.0664
Gnomad4 AMR exome
AF:
0.00369
Gnomad4 ASJ exome
AF:
0.00671
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000296
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000334
Gnomad4 OTH exome
AF:
0.00436
GnomAD4 genome
AF:
0.0181
AC:
2026
AN:
111728
Hom.:
45
Cov.:
23
AF XY:
0.0155
AC XY:
527
AN XY:
33928
show subpopulations
Gnomad4 AFR
AF:
0.0615
Gnomad4 AMR
AF:
0.00740
Gnomad4 ASJ
AF:
0.00794
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000376
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000376
Gnomad4 OTH
AF:
0.0111
Alfa
AF:
0.00455
Hom.:
98
Bravo
AF:
0.0218
EpiCase
AF:
0.000164
EpiControl
AF:
0.000357

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJul 30, 2018- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.41
DANN
Benign
0.70

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4646179; hg19: chrX-15584420; API